MANZO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.543
EU - Europa 1.067
AS - Asia 691
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 3.305
Nazione #
US - Stati Uniti d'America 1.527
CN - Cina 631
IE - Irlanda 345
UA - Ucraina 154
FI - Finlandia 144
IT - Italia 120
DE - Germania 114
SE - Svezia 96
SG - Singapore 52
GB - Regno Unito 41
BE - Belgio 17
CA - Canada 16
FR - Francia 16
CZ - Repubblica Ceca 8
RU - Federazione Russa 5
BR - Brasile 2
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
AT - Austria 1
AU - Australia 1
HK - Hong Kong 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
MU - Mauritius 1
RO - Romania 1
TR - Turchia 1
Totale 3.305
Città #
Dublin 345
Chandler 323
Jacksonville 218
Nanjing 169
Ashburn 106
Boardman 103
Nanchang 77
Princeton 69
Lawrence 66
Wilmington 65
Changsha 58
Ann Arbor 57
Helsinki 57
New York 57
Beijing 56
Hebei 56
Shenyang 56
Jiaxing 40
Medford 40
Singapore 36
Shanghai 33
Pavia 31
Milan 23
Tianjin 23
Piscataway 21
Hangzhou 19
Brussels 17
Toronto 12
Woodbridge 12
Munich 9
Seattle 9
Washington 9
Brno 8
Norwalk 8
Fairfield 7
Houston 6
Tappahannock 5
Zhengzhou 5
Auburn Hills 4
Dearborn 4
Kunming 4
Los Angeles 4
Ningbo 4
Sassari 4
Taizhou 4
Verona 4
Berlin 3
Bollate 3
London 3
Rome 3
Segrate 3
Sona 3
Buffalo 2
Casorate Primo 2
Dallas 2
Enfield 2
Fremont 2
Fuzhou 2
Jinan 2
Lanzhou 2
Madrid 2
Margherita Di Savoia 2
Menlo Park 2
Monza 2
Newark 2
Padova 2
Rozzano 2
Santa Clara 2
Stradella 2
Turin 2
Andover 1
Bolzano 1
Borås 1
Buccinasco 1
Busto Arsizio 1
Changchun 1
Chongqing 1
Des Moines 1
Elk Grove Village 1
Fort St. James 1
Frankfurt am Main 1
Gostar 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Hong Kong 1
Jinhua 1
Lungavilla 1
Messina 1
Moscow 1
Nanaimo 1
Nerima 1
Orange 1
Ottawa 1
Philadelphia 1
Pingdingshan 1
Pune 1
Redmond 1
Redwood City 1
Totale 2.427
Nome #
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 85
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 82
T o B nell’Artrite Reumatoide 78
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 75
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 75
Chemochine linfoidi nella sinovite reumatoide 75
Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane 73
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 73
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium 72
Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets 72
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 69
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome 69
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 69
Current concepts and new developments in the treatment of psoriatic arthritis 69
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 67
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 67
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling 64
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 61
Meccanismi di danno articolare in corso di artrite reumatoide 60
Nuovi aspetti patogenetici dell’artrite reumatoide 60
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 60
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 57
B cell autoimmunity and bone damage in rheumatoid arthritis 55
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment 54
Lymphoid tissue reactions in rheumatoid arthritis 53
Synovial tissue heterogeneity and peripheral blood biomarkers 53
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 53
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 52
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives 52
La membrana sinoviale 51
Human single-chain variable fragment that specifically targets arthritic cartilage 50
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? 50
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 50
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs 49
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 49
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency 47
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases 46
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis 46
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases 46
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 44
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis. 43
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 41
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 40
The synovial membrane as a prognostic tool in rheumatoid arthritis 39
La linfoneogenesi 38
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter-Determining Validation Requirements 38
Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice 36
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. 36
The Clinical Value of Autoantibodies in Rheumatoid Arthritis. 36
Established rheumatoid arthritis. The pathogenic aspects. 36
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 36
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint 35
Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice 35
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis 35
Synovial tissue research: a state-of-the-art review 34
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 33
Clinical Applications of Synovial Biopsy. 33
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials 32
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease 32
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 31
Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure 31
Insights Into the Concept of Rheumatoid Arthritis Flare 31
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic 30
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 29
ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis 28
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups. 26
Histopathology of the synovial tissue: Perspectives for biomarker development in chronic inflammatory arthritides. 25
Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective 25
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. 20
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 18
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course 17
Seronegative rheumatoid arthritis: one year in review 2023 16
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: A consensus of the eular synovitis and omeract synovial tissue biopsy groups (Arthritis Research and Therapy (2018) 20 (265) DOI: 10.1186/s13075-018-1762-1) 15
The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis 14
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis 12
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 10
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis 8
ERRATUM to: Synovial tissue research: a state-of-the-art review (Nature Reviews Rheumatology 13, 463–475 (2017)) 8
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 6
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors 5
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat 3
Totale 3.528
Categoria #
all - tutte 16.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 0 36 9 39 3 40 47 2
2020/2021338 40 27 11 33 1 38 5 52 19 52 45 15
2021/2022280 5 2 13 12 3 19 4 28 10 9 38 137
2022/20231.018 107 75 6 72 94 93 2 57 402 10 34 66
2023/2024478 39 110 17 33 39 140 13 28 4 8 28 19
2024/2025199 20 86 16 15 10 52 0 0 0 0 0 0
Totale 3.528